Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
AI Summary
Preliminary research suggests that the weight-loss drugs Ozempic and Wegovy, which contain semaglutide, may have the potential to slow biological aging, as indicated by improved markers in adults with HIV. This discovery, if validated by larger studies, could revolutionize our understanding of aging and open new avenues for treatments that extend healthy lifespan. While the results are promising, experts emphasize the need for more extensive research to confirm these effects in the broader population.
Original Source
Read the full article at Sciencedaily →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.